American Portfolios Advisors Sangamo Therapeutics, Inc Transaction History

American Portfolios Advisors

  • $2.36 Trillion
  • Q3 2022

A detailed history of American Portfolios Advisors transactions in Sangamo Therapeutics, Inc stock. As of the latest transaction made, American Portfolios Advisors holds 450 shares of SGMO stock, worth $526. This represents 0.0% of its overall portfolio holdings.

Number of Shares
450
Holding current value
$526
% of portfolio
0.0%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Mar 17, 2023
BUY
$4.27 - $6.39 $1,921 - $2,875
450 New
450 $2.21 Million
Q4 2020

Mar 22, 2023
SELL
$9.23 - $18.18 $923 - $1,818
-100 Reduced 22.22%
350 $5.46 Million
Q3 2020

Mar 22, 2023
BUY
$9.38 - $12.48 $1,641 - $2,184
175 Added 38.89%
625 $5.91 Million
Q1 2020

Mar 24, 2023
BUY
$5.05 - $8.85 $883 - $1,548
175 Added 38.89%
625 $3.98 Million
Q4 2019

Mar 24, 2023
BUY
$8.03 - $11.7 $1,405 - $2,047
175 Added 38.89%
625 $5.23 Million
Q3 2019

Mar 24, 2023
SELL
$9.05 - $12.22 $2,715 - $3,666
-300 Reduced 32.43%
625 $5.66 Million
Q2 2019

Mar 24, 2023
BUY
$8.75 - $13.03 $4,156 - $6,189
475 Added 105.56%
925 $9.96 Million
Q1 2019

Mar 24, 2023
BUY
$7.72 - $12.81 $772 - $1,281
100 Added 12.12%
925 $8.83 Million
Q4 2018

Mar 24, 2023
SELL
$9.51 - $16.6 $951 - $1,660
-100 Reduced 10.81%
825 $9.47 Million
Q3 2018

Mar 24, 2023
BUY
$13.05 - $19.05 $6,198 - $9,048
475 Added 105.56%
925 $15.7 Million
Q2 2018

Mar 24, 2023
BUY
$13.9 - $19.8 $10,077 - $14,355
725 Added 362.5%
925 $13.1 Million
Q1 2018

Mar 24, 2023
SELL
$16.7 - $26.35 $4,175 - $6,587
-250 Reduced 55.56%
200 $3.8 Million
Q4 2017

Mar 24, 2023
SELL
$11.6 - $17.35 $4,060 - $6,072
-350
100 $1.64 Million

Others Institutions Holding SGMO

# of Institutions
134
Shares Held
52.5M
Call Options Held
1.02M
Put Options Held
1.61M
View Full List

About SANGAMO THERAPEUTICS, INC

SGMO Quotes by TradingView
  • Ticker SGMO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 156,552,992
  • Market Cap $183M
  • Description
  • Sangamo Therapeutics, Inc., a clinical-stage biotechnology company, focuses on translating science into genomic medicines that transform patients' lives using platform technologies in gene therapy, cell therapy, genome editing, and genome regulation. The company offers zinc finger protein (ZFP), a technology platform for making zinc finger nucle...
More about SGMO
Track This Portfolio

Track American Portfolios Advisors Portfolio

Follow American Portfolios Advisors and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of American Portfolios Advisors, based on Form 13F filings with the SEC.

News

Stay updated on American Portfolios Advisors with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email